KYTX Competitors & Alternatives
Compare Kyverna Therapeutics, Inc. Common Stock with similar stocks in the same industry
Biotechnology
KYTX
Main Stock$5.39
Tradestie Score
58
Market Cap
$258.18M
Analyst Upside
+464.0%
Top Competitors
220 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
DSGN
Design Therapeutics, Inc. Common Stock
|
$10.24
|
$386.68M | - | 53 | Compare |
|
AURA
Aura Biosciences, Inc. Common Stock
|
$6.30
|
$382.04M | - | 51 | Compare |
|
DRTS
Alpha Tau Medical Ltd. Ordinary Shares
|
$13.16
|
$371.64M | - | 61 | Compare |
|
CGEM
Cullinan Therapeutics, Inc. Common Stock
|
$14.37
|
$354.45M | - | 47 | Compare |
|
LBRX
LB Pharmaceuticals Inc Common Stock
|
$38.73
|
$353.70M | 394.2 | 48 | Compare |
|
PROK
ProKidney Corp. Class A Ordinary Shares
|
$1.41
|
$350.98M | - | 68 | Compare |
|
ANNX
Annexon, Inc. Common Stock
|
$3.75
|
$332.96M | - | 44 | Compare |
|
REPL
Replimune Group, Inc.
|
$11.46
|
$328.62M | - | 49 | Compare |
|
EPRX
Eupraxia Pharmaceuticals Inc. Common Stock
|
$6.87
|
$307.12M | - | 63 | Compare |
|
CADL
Candel Therapeutics, Inc. Common Stock
|
$8.03
|
$304.12M | - | 59 | Compare |
More KYTX Analysis
Data updated: Oct 23, 2026 | Industry: Biotechnology (SIC 2836)
220 stocks in this industry